Reconstitution of skin fibrosis development using a tissue engineering approach

Methods in Molecular Biology

Volumn 961, Issue , 2013, Pages 287-303

  Moulin, Véronique J ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Fibrosis; Hypertrophic scar; Reconstructed tissues; Scleroderma; Skin; Skin substitutes; Tissue engineering

Indexed keywords

ARTICLE; CELL FUNCTION; CRYOPRESERVATION; DERMIS; EPIDERMIS; EXTRACTION; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HYPERTROPHIC SCAR; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MONOLAYER CULTURE; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY; SKIN FIBROSIS; SKIN RECONSTITUTION; THAWING; TISSUE AND ORGAN PREPARATION AND CULTURE; TISSUE ENGINEERING; CELL CULTURE; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; FIBROSIS; LOCALIZED SCLERODERMA; METHODOLOGY; PATHOLOGY; SCLEREDEMA; SKIN; SKIN DISEASE; SYSTEMIC SCLEROSIS;

CELL CULTURE TECHNIQUES; CELL SEPARATION; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; CRYOPRESERVATION; FIBROBLASTS; FIBROSIS; HUMANS; KERATINOCYTES; SCLEREDEMA ADULTORUM; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SKIN; SKIN DISEASES; TISSUE ENGINEERING;

MLCS; MLOWN;

EID: 84879287046     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-227-8_19     Document Type: Article

References (31)

1. Ramos ML, Gragnani A, Ferreira LM (2008) Is there an ideal animal model to study hypertrophic scarring? J Burn Care Res 29:363-368
2. Chujo S et al (2005) Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. J Cell Physiol 203:447-456
3. Fleischmajer R et al (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400-403
4. Arakawa M et al (1996) Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue. Br J Dermatol 134:863-868
5. Dasu MR et al (2004) Gene expression profiles from hypertrophic scarfibroblasts before and after IL-6 stimulation. J Pathol 202:476-485
6. Ghahary A et al (1992) Differential expression of type I and type III procollagen mRNA in human hypertrophic burn fibroblasts. Biomed Lett 47:169-184
7. Ghahary A et al (2001) Keratinocyte differentiation inversely regulates the expression of involucrin and transforming growth factor beta1. J Cell Biochem 83:239-248
8. Moulin V et al (1999) What's new in human wound healing myo fibroblasts? Curr Top Pathol 93:123-133
9. Minuth WW, Sittinger M, Kloth S (1998) Tissue engineering: generation of differentiated artificial tissues for biomedical applications. Cell Tissue Res 291:1-11
10. Germain L et al (2002) Engineering human tissues for in vivo applications. Ann N Y Acad Sci 961:268-270
11. Harrison CA et al (2006) Use of an in vitro model of tissue-engineered human skin to study keratinocyte attachment and migration in the process of reepithelialization. Wound Repair Regen 14:203-209
12. Dubé J et al (2010) Restoration of the transepithelial potential within tissue-engineered human skin in vitro and during the wound healing process in vivo. Tissue Eng Part A 16:3055-3063
13. Bechetoille N et al (2007) Effects of solar ultraviolet radiation on engineered human skin equivalent containing both Langerhans cells and dermal dendritic cells. Tissue Eng 13:2667-2679
14. Jean J, Soucy J, Pouliot R (2011) Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model. Tissue Eng Part A 17:1859-1868
15. Paquette JS et al (2004) Tissue-engineered human asthmatic bronchial equivalents. Eur Cell Mater 7:1-11, discussion 1-11
16. Corriveau M et al (2009) Fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvment. J Pathol 217:534-542
17. Bellemare J et al (2005) Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scar. J Pathol 206:1-8
18. Boyce ST et al (2006) Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns. J Trauma 60:821-829
19. Auger FA et al (2004) Tissue engineered skin substitutes: from in vitro constructs to in vivo applications. Biotechnol Appl Biochem 39:263-275
20. Michel M et al (1999) Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell Dev Biol Anim 35: 318-326
21. Carrier P et al (2009) Impact of cell source on human cornea reconstructed by tissue engineering. Invest Ophthalmol Vis Sci 50:2645-2652
22. L'Heureux N et al (1998) A completely biological tissue-engineered human blood vessel. FASEB J 12:47-56
23. Bouhout S et al (2010) In vitro reconstruction of an autologous, watertight, and resistant vesical equivalent. Tissue Eng Part A 16: 1539-1548
24. Vermette M et al (2007) Production of a new tissue-engineered adipose substitute from human adipose-derived stromal cells. Biomaterials 28:2850-2860
25. Chabaud S et al (2011) Decreased secretion of MMP by non-lesional late-stage scleroderma fibroblasts after selection via activation of the apoptotic Fas-pathway. J Cell Physiol 226:1907-1914
26. Moulin V et al (2004) Normal skin wound and hypertrophic scar myo fibroblasts have differential responses to apoptotic inductors. J Cell Physiol 198:350-358
27. Larochelle S et al (2004) Sensitivity of myo fibroblasts to H2O2-mediated apoptosis and their antioxidant cell network. J Cell Physiol 200:263-271
28. Germain L et al (1993) Improvement of human keratinocyte isolation and culture using thermolysin. Burns 19(2):99-104
29. Bogatkevich GS et al (2003) Contractile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myo fibroblasts. Am J Physiol Lung Cell Mol Physiol 285: L334-L343
30. Garner WL et al (1995) Hypertrophic scarfibroblasts accelerate collagen gel contraction. Wound Repair Regen 3:185-191
31. Moulin V et al (1996) In vitro models to study wound healing fibroblasts. Burns 22:359-362